Bicycle Therapeutics (NASDAQ:BCYC) just reported results for the first quarter of 2024.
- Bicycle Therapeutics reported earnings per share of -62 cents. This was above the analyst estimate for EPS of -$1.24.
- The company reported revenue of $19.53 million.
- This was 223.88% better than the analyst estimate for revenue of $6.03 million.